HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Indomethacin, dazoxiben and extravascular lung water after Escherichia coli infusion.

Abstract
The effects of selectively inhibiting synthesis of thromboxane A2 (TXA2) with dazoxiben and of all cyclooxygenase products with indomethacin were studied in goats after infusion of 5 X 10(8) live Escherichia coli bacteria/kg. Pulmonary and systemic pressures, cardiac output, and double indicator dilution extravascular lung water (EVLW) were measured at 15-min intervals. EVLW was determined gravimetrically at 6 hr to confirm the final double indicator dilution values. Plasma levels of TXA2 and prostacyclin (PGI2) were measured as their stable metabolites, TXB2 and 6-keto-PGF1 alpha, respectively. Dazoxiben blocked the increase in plasma TXB2, prevented pulmonary hypertension, and attenuated the increase in EVLW after E. coli. Mean gravimetric EVLW was 8.7 ml/kg in the dazoxiben-treated group compared to 11.3 ml/kg in the untreated control group. Indomethacin blocked the increased plasma TXB2 and 6-keto-PGF1 alpha, attenuated pulmonary hypertension, and prevented almost all increases in EVLW. Mean gravimetric EVLW was 8.2 ml/kg after indomethacin. We conclude that in acute bacteremia, the early pulmonary hypertension is mediated largely by TXA2 (however, a second phase of hypertension results from non-cyclooxygenase products), either production of cyclooxygenase products (perhaps PGI2) inhibits part of the action of pulmonary vasoconstrictors, or indomethacin stimulates the production of other vasoconstrictors (such as lipoxygenase products), and indomethacin prevents the accumulation of EVLW by blocking formation of cyclooxygenase products or by other nonspecific actions.
AuthorsS Price, J Harlan, C J Carrico, J Hildebrandt, R Winn
JournalThe Journal of surgical research (J Surg Res) Vol. 41 Issue 2 Pg. 189-97 (Aug 1986) ISSN: 0022-4804 [Print] United States
PMID3093772 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Cyclooxygenase Inhibitors
  • Imidazoles
  • dazoxiben
  • Thromboxane A2
  • Prostaglandin-Endoperoxide Synthases
  • Indomethacin
Topics
  • Animals
  • Body Water (metabolism)
  • Cyclooxygenase Inhibitors
  • Escherichia coli Infections (physiopathology)
  • Female
  • Imidazoles (pharmacology)
  • Indomethacin (pharmacology)
  • Lung (metabolism)
  • Male
  • Prostaglandin-Endoperoxide Synthases (physiology)
  • Sepsis (physiopathology)
  • Thromboxane A2 (antagonists & inhibitors, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: